Tumor-derived OBP2A promotes prostate cancer castration resistance.
Jeong JH, Zhong S, Li F, Huang C, Chen X, Liu Q, Peng S, Park H, Lee YM, Dhillon J, Luo JL.
Jeong JH, et al.
J Exp Med. 2023 Mar 6;220(3):e20211546. doi: 10.1084/jem.20211546. Epub 2022 Dec 22.
J Exp Med. 2023.
PMID: 36547668
Free PMC article.